Out of these biomarkers, IL-1β also exhibited prognostic significance, being associated with survival, stage-specific expression, and disease-free status, and was aberrantly expressed in early-stage CRC in our validation cohort. The gene discussed is IL1B; the disease is colorectal carcinoma.